OncoCyte (OCX) Misses Q2 EPS by 36c

OncoCyte (NASDAQ: OCX) reported Q2 EPS of ($0.36). Revenue for the quarter came in at $100 thousand.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

You May Also Be Interested In

• Crusoe in talks to raise $3B in funding - Bloomberg
• Faraday Future schedules stockholder meeting, eyes name change
• Lockheed Martin (LMT) In Lead To Buy Ultra Maritime For ~$3.5B - FT